switching from glp 1 to tirzepatide vs. Semaglutide: What You Should Know How Does Tirzepatide Work? |

Abstract Objective: This study aimed to explore the risk factors for gastrointestinal side effects (GISEs) in patients with type 2 diabetes mellitus (T2DM) during treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) based on real-world data and to develop a prediction model for GLP-1RA-related GISEs

It is also used to help optimize fat metabolism for maintaining healthy weight levels

Clinical Trial Data Show Reduced Drug Response To understand how GLP-1 resistance affects treatment outcomes, the team analyzed data from several clinical trials involving people with diabetes

The TRIUMPH-CVOT cardiovascular outcomes trial will provide longer-term safety data